CME Webcast Provides a Thyroid Update

OSUWexnerbloglogo2014 CME Webcast Provides a Thyroid Update. Overall, 20 million Americans have some form of thyroid disease and over their lifetimes, 1 out of every 8 women will develop a thyroid disease. On this CME webcast, we’re going to hear about the spectrum of thyroid disorders. Joining our moderator in the studio is endocrinologist and Assistant Professor of Internal Medicine, Dr. Elizabeth Buschur.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the diagnosis and management of hypo- and hyperthyroidism; DIAGNOSE and manage a thyroid nodule.

You’ll also learn about the following:

  • Risk factors for thyroid disease
  • Epidemiology of thyroid disease
  • Thyroid storm
  • Myxedema coma
  • Choosing a thyroid replacement product
  • Over-the-counter animal thyroid replacement
  • Thyroid drug interactions
  • T3 levels, thyroglobulin antibodies, and thyroid peroxidase antibodies
  • Approach to the incidental goiter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches On Prostate Cancer Treatment

OSUWexnerbloglogo2014 CME Webcast Teaches On Prostate Cancer Treatment. Last year on MedNet21, urologist Dr. Ahmad Shabsigh gave us an overview about some of the controversy surrounding prostate cancer screening and laid out some very thoughtful and rational recommendations about who should be screened. On this CME webcast, we’re going to look at prostate cancer treatment. We’re pleased to welcome back to the studio Assistant Professor of Urology Dr. Ahmad Shabsigh who is going to update us on the surgical management of prostate cancer. And then to update us on the medical management of prostate cancer, we have Associate Professor of Internal Medicine and oncologist at the James Cancer Hospital, Dr. Paul Monk.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the role of new prognostication tools; and REVIEW new treatment options for localized prostate cancer.

You’ll also learn about the following:

  • Surgical decision making in prostate cancer
  • Medical management of advanced prostate cancer
  • What to expect during your prostatectomy
  • Urinary incontinence and impotence after different forms of treatment
  • Choosing an androgen deprivation therapy
  • Testosterone levels in advanced prostate cancer
  • PSA levels in advanced prostate cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.